We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
Cap. Flow
-$1.08B
Cap. Flow %
-56.34%
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Technology 12.34%
3 Consumer Discretionary 8.56%
4 Industrials 7.99%
5 Healthcare 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UEC icon
1126
Uranium Energy
UEC
$5.63B
$41.2K ﹤0.01%
+10,625
New +$40.3K
PAYS icon
1127
Paysign
PAYS
$707M
$41.2K ﹤0.01%
+15,968
New +$39.9K
RXT icon
1128
Rackspace Technology
RXT
$1.2B
$40.2K ﹤0.01%
+13,638
New +$57.6K
CERS icon
1129
Cerus
CERS
$508M
$38.5K ﹤0.01%
10,540
-9,724
-48% -$36.7K
TAST
1130
DELISTED
Carrols Restaurant Group, Inc.
TAST
$38.1K ﹤0.01%
27,992
RSX
1131
DELISTED
VanEck Russia ETF
RSX
$37.1K ﹤0.01%
13,122
GSAT icon
1132
CALL
Globalstar
GSAT
$10.9B
$36.3K ﹤0.01%
1,820
-87
-5% -$2.29K
SRZN icon
1133
Surrozen
SRZN
$295M
$35.9K ﹤0.01%
4,113
-810
-16% -$17.1K
KORE
1134
DELISTED
KORE Group Holdings
KORE
$35.2K ﹤0.01%
+5,582
New +$64.2K
CMRX
1135
DELISTED
Chimerix, Inc.
CMRX
$35K ﹤0.01%
+18,800
New +$36.8K
EMBK
1136
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$33.5K ﹤0.01%
+10,194
New +$49.8K
JWACR
1137
DELISTED
Jupiter Wellness Acquisition Corp. Right
JWACR
$33.5K ﹤0.01%
335,000
KRON
1138
DELISTED
Kronos Bio
KRON
$33.1K ﹤0.01%
20,410
+2,300
+13% +$5.29K
NAUT icon
1139
Nautilus Biotechnolgy
NAUT
$110M
$31.2K ﹤0.01%
17,344
MVLAW
1140
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$29.9K ﹤0.01%
130,000
ACHV icon
1141
Achieve Life Sciences
ACHV
$685M
$29K ﹤0.01%
11,845
-1,316
-10% -$3.38K
MCAGR
1142
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$28.5K ﹤0.01%
125,000
SKIL icon
1143
Skillsoft
SKIL
$83.5M
$28.3K ﹤0.01%
+1,090
New +$36.3K
NFYS.WS
1144
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$27.6K ﹤0.01%
306,250
PSNYW icon
1145
Polestar Automotive Holding ADS Class C-1
PSNYW
$372M
$26.9K ﹤0.01%
801
+102
+15% +$3.19K
PRAX icon
1146
Praxis Precision Medicines
PRAX
$10.2B
$26.4K ﹤0.01%
+740
New +$23.1K
ACHR icon
1147
Archer Aviation
ACHR
$4.78B
$26.4K ﹤0.01%
+14,100
New +$34.8K
RDW icon
1148
Redwire
RDW
$3.28B
$26.4K ﹤0.01%
+13,310
New +$30.7K
AMRX icon
1149
Amneal Pharmaceuticals
AMRX
$5.71B
$25K ﹤0.01%
+12,562
New +$28.2K
HYLN icon
1150
Hyliion Holdings
HYLN
$701M
$24.5K ﹤0.01%
+10,472
New +$28.4K

Similar funds

Prelude Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.

  • Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
  • Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
  • Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
  • Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
  • Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.